Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes

Journal of Immunology Research · 2024 · PMC10914431

Europe PMC

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

an increasing trendP =0.06so close (0.05 < p ≤ 0.1)

EAT-2 expression increased significantly in K562 and U266, and an increasing trend was observed in RPMI 8226 ( P =0.06) and MM.1S ( P =0.08) at 4 hr in the Elo-treated group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.